These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7685150)

  • 21. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
    Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
    Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010.
    Krenács L; Tiszalvicz L; Krenács T; Boumsell L
    J Pathol; 1993 Oct; 171(2):99-104. PubMed ID: 7506772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
    Swanson SA; Brooks JJ
    Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas.
    Leers MP; Theunissen PH; Ramaekers FC; Schutte B
    Cytometry; 1997 Mar; 27(3):283-9. PubMed ID: 9041118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
    Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M
    Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the proliferative activity in neuroblastoma.
    Rudolph P; Lappe T; Hero B; Berthold F; Parwaresch R; Harms D; Schmidt D
    Am J Pathol; 1997 Jan; 150(1):133-45. PubMed ID: 9006330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas.
    Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A
    Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma.
    Drach J; Gattringer C; Glassl H; Schwarting R; Stein H; Huber H
    Cytometry; 1989 Nov; 10(6):743-9. PubMed ID: 2684579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative activity in non-Hodgkin's lymphomas and chronic lymphocytic leukemias as determined on cytological samples by Ki 67 monoclonal antibody.
    Musto P; Melillo L; Lombardi G; Aieta M; Di Renzo N; Carotenuto M
    Haematologica; 1990; 75(6):583-4. PubMed ID: 2098303
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.
    Leoncini L; Del Vecchio MT; Megha T; Barbini P; Galieni P; Pileri S; Sabattini E; Gherlinzoni F; Tosi P; Kraft R
    Am J Pathol; 1993 Mar; 142(3):755-63. PubMed ID: 7681257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma.
    Erlanson M; Casiano CA; Tan EM; Lindh J; Roos G; Landberg G
    Mod Pathol; 1999 Jan; 12(1):69-74. PubMed ID: 9950165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.
    Falini B; Flenghi L; Pileri S; Gambacorta M; Bigerna B; Durkop H; Eitelbach F; Thiele J; Pacini R; Cavaliere A
    Am J Pathol; 1993 May; 142(5):1359-72. PubMed ID: 7684194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
    Gelb AB; Kamel OW; LeBrun DP; Warnke RA
    Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.
    Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G
    Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic importance of nuclear morphometry and the MIB-1 index in rhabdomyosarcoma [corrected].
    Noguchi S; Tamiya S; Nagoshi M; Suita S; Fukuda T; Tsuneyoshi M
    Mod Pathol; 1996 Mar; 9(3):253-60. PubMed ID: 8685224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.
    Yu CC; Filipe MI
    Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction.
    Inghirami G; Szabolcs MJ; Yee HT; Corradini P; Cesarman E; Knowles DM
    Lab Invest; 1993 Jun; 68(6):746-57. PubMed ID: 8515660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.
    Schwarting R; Gerdes J; Dürkop H; Falini B; Pileri S; Stein H
    Blood; 1989 Oct; 74(5):1678-89. PubMed ID: 2477085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.